Cobey S - Search Results

1

Pierce CA, Herold KC, Herold BC, Chou J, Randolph A, Kane B, McFarland S, Gurdasani D, Pagel C, Hotez P, Cobey S, Hensley SE. Pierce CA, et al. Among authors: cobey s. Science. 2022 Sep 9;377(6611):1144-1149. doi: 10.1126/science.ade1675. Epub 2022 Sep 8. Science. 2022. PMID: 36074833 Free PMC article.

2

Investigate the origins of COVID-19.

Bloom JD, Chan YA, Baric RS, Bjorkman PJ, Cobey S, Deverman BE, Fisman DN, Gupta R, Iwasaki A, Lipsitch M, Medzhitov R, Neher RA, Nielsen R, Patterson N, Stearns T, van Nimwegen E, Worobey M, Relman DA. Bloom JD, et al. Among authors: cobey s. Science. 2021 May 14;372(6543):694. doi: 10.1126/science.abj0016. Science. 2021. PMID: 33986172 Free PMC article. No abstract available.

3

Immune history and influenza virus susceptibility.

Cobey S, Hensley SE. Cobey S, et al. Curr Opin Virol. 2017 Feb;22:105-111. doi: 10.1016/j.coviro.2016.12.004. Epub 2017 Jan 12. Curr Opin Virol. 2017. PMID: 28088686 Free PMC article. Review.

4

Model-informed COVID-19 vaccine prioritization strategies by age and serostatus.

Bubar KM, Reinholt K, Kissler SM, Lipsitch M, Cobey S, Grad YH, Larremore DB. Bubar KM, et al. Among authors: cobey s. Science. 2021 Feb 26;371(6532):916-921. doi: 10.1126/science.abe6959. Epub 2021 Jan 21. Science. 2021. PMID: 33479118 Free PMC article.

5

Comparison of Human H3N2 Antibody Responses Elicited by Egg-Based, Cell-Based, and Recombinant Protein-Based Influenza Vaccines During the 2017-2018 Season.

Gouma S, Zost SJ, Parkhouse K, Branche A, Topham DJ, Cobey S, Hensley SE. Gouma S, et al. Among authors: cobey s. Clin Infect Dis. 2020 Sep 12;71(6):1447-1453. doi: 10.1093/cid/ciz996. Clin Infect Dis. 2020. PMID: 31598646 Free PMC article.

6

Modeling infectious disease dynamics.

Cobey S. Cobey S. Science. 2020 May 15;368(6492):713-714. doi: 10.1126/science.abb5659. Epub 2020 Apr 24. Science. 2020. PMID: 32332062 No abstract available.

7

Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.

Zost SJ, Parkhouse K, Gumina ME, Kim K, Diaz Perez S, Wilson PC, Treanor JJ, Sant AJ, Cobey S, Hensley SE. Zost SJ, et al. Among authors: cobey s. Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):12578-12583. doi: 10.1073/pnas.1712377114. Epub 2017 Nov 6. Proc Natl Acad Sci U S A. 2017. PMID: 29109276 Free PMC article.

8

Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibility.

Gouma S, Kim K, Weirick ME, Gumina ME, Branche A, Topham DJ, Martin ET, Monto AS, Cobey S, Hensley SE. Gouma S, et al. Among authors: cobey s. Nat Commun. 2020 Sep 11;11(1):4566. doi: 10.1038/s41467-020-18465-x. Nat Commun. 2020. PMID: 32917903 Free PMC article.

9

An Egg-Derived Sulfated N-Acetyllactosamine Glycan Is an Antigenic Decoy of Influenza Virus Vaccines.

Guthmiller JJ, Utset HA, Henry C, Li L, Zheng NY, Sun W, Costa Vieira M, Zost S, Huang M, Hensley SE, Cobey S, Palese P, Wilson PC. Guthmiller JJ, et al. Among authors: cobey s. mBio. 2021 Jun 29;12(3):e0083821. doi: 10.1128/mBio.00838-21. Epub 2021 Jun 15. mBio. 2021. PMID: 34126773 Free PMC article.

10

Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012-2013.

Cobey S, Gouma S, Parkhouse K, Chambers BS, Ertl HC, Schmader KE, Halpin RA, Lin X, Stockwell TB, Das SR, Landon E, Tesic V, Youngster I, Pinsky BA, Wentworth DE, Hensley SE, Grad YH. Cobey S, et al. Clin Infect Dis. 2018 Jul 18;67(3):327-333. doi: 10.1093/cid/ciy097. Clin Infect Dis. 2018. PMID: 29471464 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

79 results

Search Page